What regulatory body establishes the standards for monographs defining drug storage?

The correct choice is the United States Pharmacopoeial Convention, as it is responsible for establishing quality standards for medicines and related substances in the United States, which include monographs that define drug storage conditions. These monographs provide detailed requirements for the identity, strength, quality, and purity of drug products, which encompass the necessary guidelines for how drugs should be properly stored to maintain their efficacy and safety.

The United States Pharmacopoeia (USP) develops and publishes these standards, which are used by manufacturers, regulators, and healthcare providers to ensure that medications meet the required quality. Proper drug storage is critical to preserving the integrity of pharmaceutical products, and the standards set by the USP ensure consistency and safety in storage practices.

In contrast, while the World Health Organization plays a significant role in global health guidelines and policies, it does not set the specific storage standards for medications. The Food and Drug Administration (FDA) regulates pharmaceuticals but primarily focuses on approval processes, manufacturing practices, and drug safety rather than specific storage monographs. The Centers for Disease Control, while it provides valuable public health information, is not involved in establishing drug storage standards.